Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
(Q40382332)
scientific article published on August 2005
scientific article published on August 2005
Language:
other details
description | scientific article published on August 2005 |
External Links
(P356) |
10.1158/1078-0432.CCR-04-2618
|
(P698) |
16115929
|
(P8608) |
release_d37w5sxv2vbnrh6btftoch476i
|